Why the study?
Does ramiprilat induce coronary vasodilation via nitric oxide, bradykinin, and prostaglandins in an in vivo canine model?
Does ramiprilat induce coronary vasodilation via nitric oxide, bradykinin, and prostaglandins in an in vivo canine model?
In a canine model, acute ramiprilat-induced vasodilation is mediated in part by nitric oxide in coronary conductance arteries and by bradykinin in resistance arteries.
Answers are grounded in this paper and cite their sources.
Supports NO-mediated epicardial and bradykinin-mediated microvascular ramiprilat effects in canines; hypothesis-generating for human coronary disease.
BACKGROUND: We studied in coronary conductance and resistance arteries the coronary vasodilator effects of the angiotensin-converting enzyme inhibitor ramiprilat and the contribution of nitric oxide, bradykinin, and prostaglandins to this vasodilation. METHODS AND RESEARCH: In seven anesthetized dogs, a Doppler guidewire was placed in the circumflex coronary artery to measure coronary flow velocity, and an ultrasound imaging catheter was introduced over the Doppler wire to measure coronary cross-sectional area. Drugs were infused directly into the left main coronary artery to minimize systemic effects. Ramiprilat increased both epicardial cross-sectional area and coronary blood flow velocity, resulting in an increase in absolute coronary blood flow. Pretreatment with N omega-nitro-L-arginine methyl ester (100 micromol/L intracoronary) to block nitric oxide synthase attenuated ramiprilat-induced increase in epicardial coronary cross-sectional area (P<.05) but not in coronary flow velocity or coronary blood flow. In contrast, pretreatment with the selective bradykinin antagonist HOE 140 (10 micromol/L) attenuated ramiprilat-induced increase in flow velocity (P<.025) and coronary blood flow (P<.05) but not epicardial coronary cross-sectional area. Pretreatment with indomethacin (5 mg/kg body wt IV) did not alter ramiprilat-induced increase in epicardial cross-sectional area, nor did it significantly influence coronary blood flow. CONCLUSIONS: Other than decreasing angiotensin II production, acute ramiprilat-induced vasodilation in canine coronary conductance arteries is mediated in part by nitric oxide. Ramiprilat-induced vasodilation in resistance arteries is in part mediated by the action of bradykinin.
No takes yet. Share an insight, caveat, or question.
Sudhir et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: